LanssonPharm Secures Series A Funding to Accelerate CNS Drug Development
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...
China Biopharma Corporation, trading on the OTC Bulletin Board under the symbol (CBPC.OB), announced a...
In a strategic response to India’s Ministry of Commerce and Industry’s (MOFCOM) anti-dumping ruling against...
Novartis (NYSE: NVS), a multinational pharmaceutical giant, has reported a robust sales revenue of nearly...
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...